Palatin Technologies vs Rani Therapeutics
PTN and RANI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PTN and RANI compare
Rani Therapeutics is the larger company, worth 6.6 times as much as Palatin Technologies ($73.4M against $11.1M).
Palatin Technologies scores higher on the StockData Score (6 against 2 for Rani Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PTN | RANI |
|---|---|---|
| Size and price | ||
| Market cap | $11.1M | $73.4M |
| Share price | $6.23 | $0.526 |
| Change, 1 year | −43.6% | −75.2% |
| Change, 5 years | −98.6% | −98.5% |
| Beta (5Y) | 0.77 | 0.85 |
| Employees | 25 | 69 |
| StockData Score | ||
| Total score | 6 (better) | 2 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 4 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 11.1× |
| P/B | 1.7× (better) | 2.2× |
| FCF yield | −122% | −31.7% (better) |
| Fair value | – | $0.366 |
| Margin of safety | – | −43.8% |
| Growth | ||
| Revenue growth (TTM) | – | 449% |
| Revenue growth, 5Y average | – | 28.7% |
| Profitability | ||
| Operating margin | – | −530% |
| Net margin | – | −493% |
| FCF margin | – | −353% |
| Return on equity | −878% | −249% (better) |
| Return on invested capital | – | −173% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −1288.8× | −71.9× (better) |
| Current ratio | 4.61 | 5.26 (better) |
| Altman Z-score | −75.61 | −1.36 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | −152% | – |
| Shareholder yield | −152% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 38.5% | 32.7% |
| Held by insiders | 20.6% | 30.6% |
| Insider net buying, 12 months | −$9.5K | $49.7K (better) |
| Short interest, % of float | 20.9% | 8.5% |
Go deeper
- PTN stock overview
- PTN income statement
- PTN valuation and score
- RANI stock overview
- RANI income statement
- RANI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.